| Literature DB >> 23478108 |
Dimitrios Ntelios1, Eleftheria Mpei, Eleftheria Gousi, Evangelos Potolidis, Panagiotis Fanourgiakis, Charalampos Mandros.
Abstract
Troponin (I or T) is the principal marker of myocardial injury used in clinical practice. Although immune-based methods to determine troponin I levels are generally reliable, the presence of human antibodies interfering with the assays components could lead to erroneous results. In this report, we will discuss the case of a patient with misleadingly elevated troponin I due to high rheumatoid factor titer and provide an insight into the responsible molecular mechanisms.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23478108 DOI: 10.1016/j.ajem.2013.01.035
Source DB: PubMed Journal: Am J Emerg Med ISSN: 0735-6757 Impact factor: 2.469